Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4HSE5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 366 | 370 | PF00656 | 0.759 |
CLV_C14_Caspase3-7 | 382 | 386 | PF00656 | 0.604 |
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.484 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.514 |
CLV_NRD_NRD_1 | 330 | 332 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 347 | 349 | PF00675 | 0.616 |
CLV_PCSK_FUR_1 | 320 | 324 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 322 | 324 | PF00082 | 0.410 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 347 | 349 | PF00082 | 0.616 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.570 |
CLV_PCSK_PC1ET2_1 | 218 | 220 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 319 | 321 | PF00082 | 0.522 |
CLV_PCSK_PC7_1 | 320 | 326 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 254 | 258 | PF00082 | 0.604 |
DEG_Kelch_Keap1_1 | 374 | 379 | PF01344 | 0.622 |
DOC_MAPK_MEF2A_6 | 172 | 181 | PF00069 | 0.662 |
DOC_SPAK_OSR1_1 | 240 | 244 | PF12202 | 0.577 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 247 | 251 | PF00917 | 0.548 |
DOC_USP7_MATH_1 | 357 | 361 | PF00917 | 0.690 |
DOC_WW_Pin1_4 | 173 | 178 | PF00397 | 0.569 |
DOC_WW_Pin1_4 | 222 | 227 | PF00397 | 0.462 |
DOC_WW_Pin1_4 | 276 | 281 | PF00397 | 0.513 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.535 |
LIG_14-3-3_CanoR_1 | 172 | 177 | PF00244 | 0.563 |
LIG_Actin_WH2_2 | 77 | 93 | PF00022 | 0.458 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.493 |
LIG_CtBP_PxDLS_1 | 178 | 182 | PF00389 | 0.542 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.487 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.566 |
LIG_FHA_1 | 193 | 199 | PF00498 | 0.598 |
LIG_FHA_1 | 290 | 296 | PF00498 | 0.619 |
LIG_FHA_2 | 375 | 381 | PF00498 | 0.623 |
LIG_LIR_Apic_2 | 31 | 37 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 311 | 321 | PF02991 | 0.597 |
LIG_LIR_Nem_3 | 182 | 187 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 311 | 317 | PF02991 | 0.596 |
LIG_Pex14_1 | 34 | 38 | PF04695 | 0.490 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.463 |
LIG_SH2_CRK | 184 | 188 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 328 | 331 | PF00017 | 0.632 |
LIG_SUMO_SIM_anti_2 | 292 | 297 | PF11976 | 0.512 |
LIG_SUMO_SIM_par_1 | 291 | 297 | PF11976 | 0.500 |
LIG_TRAF2_1 | 301 | 304 | PF00917 | 0.532 |
LIG_TRAF2_1 | 308 | 311 | PF00917 | 0.515 |
LIG_TRAF2_1 | 377 | 380 | PF00917 | 0.768 |
LIG_TYR_ITIM | 146 | 151 | PF00017 | 0.469 |
MOD_CDK_SPxK_1 | 276 | 282 | PF00069 | 0.621 |
MOD_CK1_1 | 203 | 209 | PF00069 | 0.674 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.410 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.460 |
MOD_CK1_1 | 360 | 366 | PF00069 | 0.728 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.556 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.598 |
MOD_CK2_1 | 367 | 373 | PF00069 | 0.751 |
MOD_CK2_1 | 374 | 380 | PF00069 | 0.668 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.518 |
MOD_GlcNHglycan | 248 | 252 | PF01048 | 0.479 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.560 |
MOD_GlcNHglycan | 361 | 365 | PF01048 | 0.782 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.681 |
MOD_GlcNHglycan | 41 | 45 | PF01048 | 0.423 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.625 |
MOD_N-GLC_1 | 286 | 291 | PF02516 | 0.529 |
MOD_N-GLC_1 | 367 | 372 | PF02516 | 0.720 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.539 |
MOD_NEK2_2 | 235 | 240 | PF00069 | 0.468 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.480 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.579 |
MOD_Plk_1 | 179 | 185 | PF00069 | 0.605 |
MOD_Plk_1 | 203 | 209 | PF00069 | 0.697 |
MOD_Plk_4 | 179 | 185 | PF00069 | 0.605 |
MOD_ProDKin_1 | 173 | 179 | PF00069 | 0.572 |
MOD_ProDKin_1 | 222 | 228 | PF00069 | 0.461 |
MOD_ProDKin_1 | 276 | 282 | PF00069 | 0.520 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.545 |
TRG_DiLeu_BaEn_2 | 309 | 315 | PF01217 | 0.604 |
TRG_DiLeu_BaEn_3 | 310 | 316 | PF01217 | 0.540 |
TRG_DiLeu_BaEn_4 | 79 | 85 | PF01217 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 147 | 152 | PF01217 | 0.566 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.423 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.468 |
TRG_ER_diArg_1 | 219 | 222 | PF00400 | 0.514 |
TRG_ER_diArg_1 | 320 | 323 | PF00400 | 0.527 |
TRG_ER_diArg_1 | 329 | 331 | PF00400 | 0.492 |
TRG_NLS_MonoExtN_4 | 216 | 222 | PF00514 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 150 | 155 | PF00026 | 0.468 |
TRG_Pf-PMV_PEXEL_1 | 240 | 244 | PF00026 | 0.445 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHU8 | Leptomonas seymouri | 46% | 93% |
A0A3S7WP15 | Leishmania donovani | 99% | 100% |
A4H470 | Leishmania braziliensis | 81% | 100% |
E9AKD1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 99% |
Q4QJH7 | Leishmania major | 88% | 100% |